Alivus Life Sciences Limited (NSE:ALIVUS)
India · Delayed Price · Currency is INR 927.40
-7.40 (-0.79%)
At close: Aug 11, 2025, 3:30 PM IST
Alivus Life Sciences Market Cap
Alivus Life Sciences has a market cap or net worth of 117.58 billion as of August 14, 2025. Its market cap has increased by 7.95% in one year.
Market Cap
117.58B
Enterprise Value
112.66B
Revenue
24.00B
Ranking
n/a
PE Ratio
23.77
Stock Price
927.40
Market Cap Chart
Since August 6, 2021, Alivus Life Sciences's market cap has increased from 91.71B to 117.58B, an increase of 28.20%. That is a compound annual growth rate of 6.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 115.82B | -3.88% |
| Dec 31, 2024 | 120.50B | 49.68% |
| Dec 29, 2023 | 80.51B | 56.38% |
| Dec 30, 2022 | 51.48B | -33.42% |
| Dec 31, 2021 | 77.32B | -15.69% |
| Aug 6, 2021 | 91.71B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,859.09B |
| Divi's Laboratories | 1,582.46B |
| Cipla | 1,229.07B |
| Apollo Hospitals Enterprise | 1,043.73B |
| Mankind Pharma | 1,006.03B |
| Zydus Lifesciences | 961.61B |
| Fortis Healthcare | 695.05B |
| Aurobindo Pharma | 611.53B |